ortholog Search Results


golgin245  (Developmental Studies Hybridoma Bank)
94
Developmental Studies Hybridoma Bank golgin245

Golgin245, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/golgin245/product/Developmental Studies Hybridoma Bank
Average 94 stars, based on 1 article reviews
golgin245 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
anti parp1  (TargetMol)
91
TargetMol anti parp1
Assembly sequence of the <t>PRMT6/PARP1/CRL4B</t> complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or <t>an</t> <t>anti‐PARP1</t> antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.
Anti Parp1, supplied by TargetMol, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti parp1/product/TargetMol
Average 91 stars, based on 1 article reviews
anti parp1 - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
1 ap  (Proteintech)
94
Proteintech 1 ap
Assembly sequence of the <t>PRMT6/PARP1/CRL4B</t> complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or <t>an</t> <t>anti‐PARP1</t> antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.
1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1 ap/product/Proteintech
Average 94 stars, based on 1 article reviews
1 ap - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
12954 1 ap  (Proteintech)
93
Proteintech 12954 1 ap
Assembly sequence of the <t>PRMT6/PARP1/CRL4B</t> complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or <t>an</t> <t>anti‐PARP1</t> antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.
12954 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/12954 1 ap/product/Proteintech
Average 93 stars, based on 1 article reviews
12954 1 ap - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
c. elegans ppef-type phosphatase (retinal degeneration c ortholog)  (Keerthana Industries)
90
Keerthana Industries c. elegans ppef-type phosphatase (retinal degeneration c ortholog)
Assembly sequence of the <t>PRMT6/PARP1/CRL4B</t> complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or <t>an</t> <t>anti‐PARP1</t> antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.
C. Elegans Ppef Type Phosphatase (Retinal Degeneration C Ortholog), supplied by Keerthana Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c. elegans ppef-type phosphatase (retinal degeneration c ortholog)/product/Keerthana Industries
Average 90 stars, based on 1 article reviews
c. elegans ppef-type phosphatase (retinal degeneration c ortholog) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
arabidopsis/medicago orthologs  (Medicago)
90
Medicago arabidopsis/medicago orthologs
Assembly sequence of the <t>PRMT6/PARP1/CRL4B</t> complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or <t>an</t> <t>anti‐PARP1</t> antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.
Arabidopsis/Medicago Orthologs, supplied by Medicago, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/arabidopsis/medicago orthologs/product/Medicago
Average 90 stars, based on 1 article reviews
arabidopsis/medicago orthologs - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
orthologs of spl-like genes  (Schmid GmbH)
90
Schmid GmbH orthologs of spl-like genes
Assembly sequence of the <t>PRMT6/PARP1/CRL4B</t> complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or <t>an</t> <t>anti‐PARP1</t> antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.
Orthologs Of Spl Like Genes, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/orthologs of spl-like genes/product/Schmid GmbH
Average 90 stars, based on 1 article reviews
orthologs of spl-like genes - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ljepr3 ortholog mtlyk10  (Medicago)
90
Medicago ljepr3 ortholog mtlyk10
Gene structure of Parasponia and Trema EPR . A Gene structure of L. japonicus <t>LjEPR3,</t> T. orientalis EPR, and the epr pseudogene in P. andersonii, P. rigida, and P. rugosa. Note retrotransposon insertion (annotated in orange) in the putative promoter region of Parasponia species. Promoter (light green), gene (green), CDS = coding DNA sequence (yellow). B LOGOs of putative NIN and ERN1 binding motifs in the promoter region of T. orientalis EPR and the epr pseudogenes of P. andersonii, P. rigida, and P. rugosa. TSS: translational start site
Ljepr3 Ortholog Mtlyk10, supplied by Medicago, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ljepr3 ortholog mtlyk10/product/Medicago
Average 90 stars, based on 1 article reviews
ljepr3 ortholog mtlyk10 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
magnesium-activated aldehyde dehydrogenase, cytosolic;ald6;ortholog  (CH Instruments)
90
CH Instruments magnesium-activated aldehyde dehydrogenase, cytosolic;ald6;ortholog
Some of the informative probe sets identified by at least four AWAs.
Magnesium Activated Aldehyde Dehydrogenase, Cytosolic;Ald6;Ortholog, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/magnesium-activated aldehyde dehydrogenase, cytosolic;ald6;ortholog/product/CH Instruments
Average 90 stars, based on 1 article reviews
magnesium-activated aldehyde dehydrogenase, cytosolic;ald6;ortholog - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
id6 orthologs  (Sawai Pharmaceutical)
90
Sawai Pharmaceutical id6 orthologs
Some of the informative probe sets identified by at least four AWAs.
Id6 Orthologs, supplied by Sawai Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/id6 orthologs/product/Sawai Pharmaceutical
Average 90 stars, based on 1 article reviews
id6 orthologs - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ncbi clusters of eukaryotic orthologous groups (kog) database  (Biotechnology Information)
90
Biotechnology Information ncbi clusters of eukaryotic orthologous groups (kog) database
Some of the informative probe sets identified by at least four AWAs.
Ncbi Clusters Of Eukaryotic Orthologous Groups (Kog) Database, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ncbi clusters of eukaryotic orthologous groups (kog) database/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
ncbi clusters of eukaryotic orthologous groups (kog) database - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ilve orthologs  (Hirotsu Bio Science Inc)
90
Hirotsu Bio Science Inc ilve orthologs
Some of the informative probe sets identified by at least four AWAs.
Ilve Orthologs, supplied by Hirotsu Bio Science Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ilve orthologs/product/Hirotsu Bio Science Inc
Average 90 stars, based on 1 article reviews
ilve orthologs - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Journal: eLife

Article Title: A conserved major facilitator superfamily member orchestrates a subset of O-glycosylation to aid macrophage tissue invasion

doi: 10.7554/eLife.41801

Figure Lengend Snippet:

Article Snippet: Anti- Golgin 245 (goat polyclonal) , DSHB, RRID: SCR_013527 , DSHB Cat# Golgin245, RRID: AB_2618260 , (1:50).

Techniques: Amplification, Clone Assay, cDNA Library Assay, Expressing, Plasmid Preparation, Staining, Software

Assembly sequence of the PRMT6/PARP1/CRL4B complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.

Journal: Advanced Science

Article Title: The PRMT6/PARP1/CRL4B Complex Regulates the Circadian Clock and Promotes Breast Tumorigenesis

doi: 10.1002/advs.202202737

Figure Lengend Snippet: Assembly sequence of the PRMT6/PARP1/CRL4B complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.

Article Snippet: The antibodies were listed as follows: anti‐FLAG (F1408), anti‐CUL4B (C9995), anti‐ β ‐actin (A1978), anti‐HDAC1 (H3284), anti‐HDAC2 (H3159), anti‐Vimentin (V6630) and anti‐Fibronectin (F3648) from Sigma‐Aldrich; anti‐DDB1 (sc‐25367) and anti‐PER1 (sc‐398890) from Santa Cruz Biotechnology; anti‐ROC1 (ab2977), anti‐H3 (ab1791), anti‐H4 (ab17840), anti‐H3R2me2a (ab194706), anti‐H3R2me2s (ab194684), anti‐H4R3me2s (ab5823), antiH4R3me2a (ab129231), anti‐H3R8me2s (ab130740), anti‐H3R8me2a (ab127163), anti‐H3K4me2 (ab32356), anti‐H3K36me1 (ab176920), anti‐H3K36me2 (ab176921), and anti‐H3K36me3 (ab194677) from Abcam; anti‐H2AK119ub1 (05‐678) from Millipore; anti‐ α ‐catenin (610193), anti‐ γ ‐catenin (610253), anti‐E‐cadherin (610181), and anti‐N‐cadherin (610920) from BD Bioscience; anti‐PRMT6 (14641S), anti‐PARP1 (9532T), and anti‐HER2 (4290) from Cell Signaling Technology; anti‐PER3 (12550‐1‐AP), anti‐LDHA (21799‐1‐AP), anti‐BHLHE40 (17895‐1‐AP), and anti‐CSNK1A1 (55192‐1‐AP) from Proteintech; anti‐PRMT6 (sc‐271744), anti‐PARP1 (sc‐8007), and anti‐PER3 (sc‐517227) from Santa; PARP inhibitor Olaparib (T3015) and Veliparib (T2591) and PRMT6 inhibitor EPZ020411 (T4334) from Topscience; small interfering RNAs targeting human PRMT6 (esiRNAs) (EHU125311) from Sigma‐Aldrich.

Techniques: Sequencing, Knockdown, Immunoprecipitation, Control, Western Blot, Stable Transfection

Gene structure of Parasponia and Trema EPR . A Gene structure of L. japonicus LjEPR3, T. orientalis EPR, and the epr pseudogene in P. andersonii, P. rigida, and P. rugosa. Note retrotransposon insertion (annotated in orange) in the putative promoter region of Parasponia species. Promoter (light green), gene (green), CDS = coding DNA sequence (yellow). B LOGOs of putative NIN and ERN1 binding motifs in the promoter region of T. orientalis EPR and the epr pseudogenes of P. andersonii, P. rigida, and P. rugosa. TSS: translational start site

Journal: BMC Plant Biology

Article Title: Pseudogenization of the rhizobium-responsive EXOPOLYSACCHARIDE RECEPTOR in Parasponia is a rare event in nodulating plants

doi: 10.1186/s12870-022-03606-9

Figure Lengend Snippet: Gene structure of Parasponia and Trema EPR . A Gene structure of L. japonicus LjEPR3, T. orientalis EPR, and the epr pseudogene in P. andersonii, P. rigida, and P. rugosa. Note retrotransposon insertion (annotated in orange) in the putative promoter region of Parasponia species. Promoter (light green), gene (green), CDS = coding DNA sequence (yellow). B LOGOs of putative NIN and ERN1 binding motifs in the promoter region of T. orientalis EPR and the epr pseudogenes of P. andersonii, P. rigida, and P. rugosa. TSS: translational start site

Article Snippet: In Medicago truncatula , the LjEPR3 ortholog MtLYK10 is crucial for the progression of the infection thread to the nodule primordia.

Techniques: Sequencing, Binding Assay

Phylogeny reconstruction of the LjEPR3/MtLYK10 orthogroup of nodulating species. Color coding indicates taxonomic orders; Cucurbitales (green, 1 species), Fagales (yellow, 3 species), Rosales (red, 4 nodulating species and two non-nodulating Trema species), Fabales (purple, 26 species). Tree rooted on outgroup ( L. japonicus LYS4 and LYS5 , M. truncatula LYK11 , and P. andersonii LYK4 ). Asterisk indicates a duplication event in the legume Papilionoideae subfamily. Bootstrap values indicate IQ-tree UF-bootstrap support%; values. The scale bar presents substitutions per site. A complete list of species and accession numbers can be found in Table S and Supplemental Data file

Journal: BMC Plant Biology

Article Title: Pseudogenization of the rhizobium-responsive EXOPOLYSACCHARIDE RECEPTOR in Parasponia is a rare event in nodulating plants

doi: 10.1186/s12870-022-03606-9

Figure Lengend Snippet: Phylogeny reconstruction of the LjEPR3/MtLYK10 orthogroup of nodulating species. Color coding indicates taxonomic orders; Cucurbitales (green, 1 species), Fagales (yellow, 3 species), Rosales (red, 4 nodulating species and two non-nodulating Trema species), Fabales (purple, 26 species). Tree rooted on outgroup ( L. japonicus LYS4 and LYS5 , M. truncatula LYK11 , and P. andersonii LYK4 ). Asterisk indicates a duplication event in the legume Papilionoideae subfamily. Bootstrap values indicate IQ-tree UF-bootstrap support%; values. The scale bar presents substitutions per site. A complete list of species and accession numbers can be found in Table S and Supplemental Data file

Article Snippet: In Medicago truncatula , the LjEPR3 ortholog MtLYK10 is crucial for the progression of the infection thread to the nodule primordia.

Techniques:

Some of the informative probe sets identified by at least four AWAs.

Journal: PLoS ONE

Article Title: Mining transcriptomic data to identify Saccharomyces cerevisiae signatures related to improved and repressed ethanol production under fermentation

doi: 10.1371/journal.pone.0259476

Figure Lengend Snippet: Some of the informative probe sets identified by at least four AWAs.

Article Snippet: A_06_P6820 , ALD6 , Chi Square Statistic, PCA, Rule, Uncertainty , 4 , Magnesium-activated aldehyde dehydrogenase, cytosolic;ALD6;ortholog.

Techniques: